Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2025-04-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically the exercise of put options on convertible bonds and the subsequent reduction in potential shares held by the reporting entity (MDS Tech) and its special related parties. This falls under the category of Major Shareholding Notification.
2025-04-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and board appointments. This aligns perfectly with the definition of a Declaration of Voting Results (DVA), which reports the official outcomes of shareholder votes at a general meeting.
2025-03-28 Korean
[기재정정]사업보고서 (2022.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Solco Biomedical, detailing corrections made to previously filed consolidated financial statements. It includes specific audit opinions, financial tables (balance sheets, income statements, etc.), and notes on financial statement restatements. It is not an Annual Report (10-K) as it focuses specifically on the audit and the correction of financial data, fitting the definition of an Audit Report/Information document. FY 2022
2025-03-20 Korean
[기재정정]사업보고서 (2023.12)
Audit Report / Information Classification · 98% confidence The document is a formal 'Correction Report' (정정신고) regarding a previously filed 'Audit Report on Financial Statements' (재무제표에 대한 감사보고서). It details specific line-item adjustments to the balance sheet, income statement, and cash flow statement for the company Solgo Biomedical. Since this is a formal correction of an audit-related financial document, it falls under the category of Audit Report / Information. FY 2023
2025-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company AlphaNox. It contains key financial data, audit opinions, and financial statements (consolidated and separate) for the fiscal year. While it provides financial data, it is a regulatory filing specifically announcing the submission of the audit report to the exchange, rather than the full 10-K annual report document itself. Therefore, it is classified as an Audit Report / Information document. FY 2024
2025-03-20 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the fiscal year 2024 (Jan 1, 2024 to Dec 31, 2024). It contains comprehensive sections including company overview, business operations, detailed financial statements (consolidated and separate), management discussion and analysis, audit information, and governance details. In the Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K annual report, providing full-year financial performance and company activity. It is not an announcement or a summary, but the full report itself. FY 2024
2025-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.